Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-01-08 @ 12:22 PM
Study NCT ID:
NCT00483860
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2007-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SKF104864/722
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None